Acropolis Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,610
| Closed | -$124K | – | 145 |
|
|
2018
Q3 | $124K | Sell |
1,610
-690
| -30% | -$53.1K | 0.02% | 129 |
|
|
2018
Q2 | $163K | Sell |
2,300
-185
| -7% | -$13.1K | 0.03% | 124 |
|
|
2018
Q1 | $187K | Sell |
2,485
-130
| -5% | -$9.78K | 0.03% | 122 |
|
|
2017
Q4 | $187K | Buy |
2,615
+255
| +11% | +$18.2K | 0.03% | 122 |
|
|
2017
Q3 | $191K | Sell |
2,360
-3,310
| -58% | -$268K | 0.03% | 115 |
|
|
2017
Q2 | $401K | Sell |
5,670
-10,805
| -66% | -$764K | 0.07% | 97 |
|
|
2017
Q1 | $1.12M | Buy |
16,475
+120
| +0.7% | +$8.15K | 0.2% | 60 |
|
|
2016
Q4 | $1.17M | Buy |
16,355
+1,770
| +12% | +$127K | 0.22% | 59 |
|
|
2016
Q3 | $1.15M | Buy |
14,585
+280
| +2% | +$22.2K | 0.21% | 53 |
|
|
2016
Q2 | $1.19M | Buy |
14,305
+965
| +7% | +$80.5K | 0.23% | 52 |
|
|
2016
Q1 | $1.23M | Buy |
13,340
+3,110
| +30% | +$286K | 0.24% | 51 |
|
|
2015
Q4 | $1.04M | Buy |
10,230
+3,930
| +62% | +$398K | 0.21% | 57 |
|
|
2015
Q3 | $619K | Buy |
+6,300
| New | +$619K | 0.13% | 75 |
|